Capital Increase / Dilution2026-07-01

CXI Healthcare to raise 33.57M HKD via private placement

CXI

씨엑스아이

900120

+0.05

Signal Score

52CNeutral
Score52 / 100

Historical Avg Return (5d)

+0.26%

Data Coverage

100%n=2435

Risk-adjusted indicator based on 2435 historical DART filings. For informational purposes only — not investment advice.

Financial Impact

NEUTRAL

Key Numbers

  • • Operating Funds: 33,570,701.93 HKD (approx. 6.60B KRW)
  • • Par Value per Share: 0.5 USD (approx. 770.75 KRW)
  • • Pre-increase Shares Outstanding: 3,700,000 Shares (as of May 20, 2026, reflecting June 12, 2026 issuance)
  • • Issuance Date: July 01, 2026

AI Analysis Summary

CXI Healthcare Technology Group Limited announced a private placement capital increase to raise 33,570,701.93 HKD (approximately 6.60 billion KRW) for operating funds. The par value per share is 0.5 USD (770.75 KRW). The issuance price will be determined with a 9.68% premium over the reference stock price. The company cited challenges in securing large-scale funding in the Korean market and the need for capital to enhance financial soundness and strengthen its going concern basis, despite potential share dilution for existing shareholders. The funds will support business operations, investment, and expansion for the company and its subsidiaries, including securing tea cultivation sites and marketing expenses.

Track Korean Market Signals — Free

Sign up free to access live disclosures, AI analysis, and event filters.

Public Beta · No credit card required

This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.

AI-processed analysis. Based on: 주요사항보고서(유상증자결정). Source: Financial Supervisory Service (금융감독원 전자공시시스템). Raw government data is not redistributed. Not investment advice.